EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Lipoprotein(a) distribution in hospitalised Asian patients with ischaemic heart disease

Wann Jia Loh iD, Chong Boon Teo, Oliver Simon, Colin Yeo

Therapeutic Advances in Cardiovascular Disease · 2024

DOI: 10.1177/17539447241306936 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Advances in Cardiovascular Disease, 2024. Verfasst von Wann Jia Loh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Changi General Hospital, 2 Simei Street 3, Singapore 529889, Singapore. Hauptthemen laut MEDLINE: Lipoprotein(a), Myocardial Ischemia, Asian People, Biomarkers. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NOVARTIS Singapore.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Elevated lipoprotein(a) [Lp(a)] is a common hyperlipidaemic condition with strong genetic predisposition and is independently associated with ischaemic heart disease (IHD). A Mendelian randomisation study has suggested that elevated Lp(a) is likely to confer similar causal risks as heterozygous familial hypercholesterolemia for premature IHD. We aimed to characterise the clinical profiles of admitted patients with IHD with at least one Lp(a) measurement. We also investigated whether elevated Lp(a) concentration was associated with premature onset of IHD.

Methods

This is a descriptive, non-interventional, retrospective study with data from a single tertiary hospital IHD Lp(a) cohort in Singapore, which consecutively recruited 521 patients with IHD admitted to the hospital.

Results

A total of 82.2% were men, 46.6% had newly diagnosed IHD and 10% had premature IHD. The median Lp(a) levels was 35.2 nmol/L. 70.8% of patients had normal Lp(a) concentrations (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipoprotein(a)Myocardial IschemiaAsian PeopleBiomarkersHumansMaleFemaleMiddle AgedRetrospective StudiesSingaporeAgedHospitalizationRisk FactorsAdultUp-RegulationRisk Assessment

Stichwörter der Autor:innen

AsianLp(a)atherosclerosiscardiovascularcoronary artery diseaseethnicityischaemic heart diseaselipoprotein(a)premature coronary artery disease

Substanzen

Lipoprotein(a)BiomarkersLPA protein, human

Autor:innen und Institutionen

  • Department of Endocrinology, Changi General Hospital, 2 Simei Street 3, Singapore 529889, Singapore.
  • Duke-NUS Medical School, Singapore, Singapore.
  • Yong Loo Lin School of Medicine, National University Singapore, Singapore, Singapore.
  • Novartis (Singapore) Pte Ltd, Singapore, Singapore.
  • Department of Cardiology, Changi General Hospital, Singapore, Singapore.

ORCID-Profile: Wann Jia Loh

Förderung

  • NOVARTIS Singapore

Zitieren

APA

Loh, W. J., Teo, C. B., Simon, O., & Yeo, C. (2024). Lipoprotein(a) distribution in hospitalised Asian patients with ischaemic heart disease. Therapeutic Advances in Cardiovascular Disease. https://doi.org/10.1177/17539447241306936

Vancouver

Loh WJ, Teo CB, Simon O, Yeo C. Lipoprotein(a) distribution in hospitalised Asian patients with ischaemic heart disease. Therapeutic Advances in Cardiovascular Disease. 2024. doi:10.1177/17539447241306936

BibTeX
@article{Loh2024,
  author = {Loh, Wann Jia and Teo, Chong Boon and Simon, Oliver and Yeo, Colin},
  title = {Lipoprotein(a) distribution in hospitalised Asian patients with ischaemic heart disease},
  journal = {Therapeutic Advances in Cardiovascular Disease},
  year = {2024},
  doi = {10.1177/17539447241306936}
}
Kostenlos starten →